Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
PREVOZNIK MICHAEL E | SVP & General Counsel | Nov 29 '24 | Option Exercise | 86.63 | 35,146 | 3,044,698 | 73,624 | Dec 02 04:43 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Nov 29 '24 | Sale | 163.07 | 35,146 | 5,731,302 | 38,478 | Dec 02 04:43 PM | Doherty Catherine T. | EVP, Regional Businesses | Nov 27 '24 | Option Exercise | 103.57 | 33,103 | 3,428,478 | 101,515 | Dec 02 04:41 PM | Doherty Catherine T. | EVP, Regional Businesses | Nov 27 '24 | Sale | 162.99 | 33,103 | 5,395,484 | 68,412 | Dec 02 04:41 PM | PREVOZNIK MICHAEL E | Officer | Nov 29 '24 | Proposed Sale | 163.07 | 35,146 | 5,731,302 | | Nov 29 02:42 PM | Doherty Catherine T. | Officer | Nov 27 '24 | Proposed Sale | 162.99 | 33,103 | 5,395,484 | | Nov 27 04:12 PM | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Nov 06 '24 | Option Exercise | 68.66 | 18,755 | 1,287,634 | 53,696 | Nov 07 05:21 PM | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Nov 06 '24 | Sale | 154.05 | 18,755 | 2,889,123 | 34,941 | Nov 07 05:21 PM | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Oct 28 '24 | Sale | 156.92 | 1,775 | 278,525 | 9,734 | Oct 30 04:26 PM | KUPPUSAMY KARTHIK | Officer | Oct 28 '24 | Proposed Sale | 156.87 | 1,775 | 278,450 | | Oct 28 12:51 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Aug 29 '24 | Option Exercise | 95.80 | 32,551 | 3,118,223 | 71,029 | Sep 03 04:30 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Aug 29 '24 | Sale | 154.97 | 32,551 | 5,044,516 | 38,478 | Sep 03 04:30 PM | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Aug 28 '24 | Sale | 153.26 | 1,990 | 304,990 | 11,459 | Aug 29 04:45 PM | PREVOZNIK MICHAEL E | Officer | Aug 29 '24 | Proposed Sale | 154.97 | 32,551 | 5,044,516 | | Aug 29 01:55 PM | KUPPUSAMY KARTHIK | Officer | Aug 28 '24 | Proposed Sale | 153.26 | 1,990 | 304,990 | | Aug 28 04:49 PM | DELANEY MARK E | SVP & Chief Commercial Officer | Jul 24 '24 | Sale | 143.08 | 420 | 60,094 | 5,019 | Jul 26 06:33 PM | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Apr 29 '24 | Sale | 140.00 | 1,760 | 246,400 | 13,435 | May 01 04:26 PM | Doherty Catherine T. | EVP, Regional Businesses | Feb 28 '24 | Sale | 126.57 | 5,557 | 703,349 | 69,599 | Mar 01 04:51 PM | Doherty Catherine T. | EVP, Regional Businesses | Feb 29 '24 | Sale | 125.88 | 1,187 | 149,420 | 68,412 | Mar 01 04:51 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 29 '24 | Sale | 125.88 | 5,611 | 706,313 | 38,478 | Mar 01 04:50 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 22 '24 | Sale | 126.14 | 661 | 83,379 | 40,206 | Feb 23 04:35 PM | Gregg Vicky B | Director | Feb 23 '24 | Sale | 126.64 | 2,500 | 316,596 | 16,329 | Feb 23 04:34 PM | Doherty Catherine T. | EVP, Regional Businesses | Feb 22 '24 | Sale | 126.14 | 821 | 103,561 | 70,800 | Feb 23 04:32 PM |
|